Background and Aims: Commercial superoxide dismutase [SOD] is derived from melon extract and has a potential as a dietary supplement due to its beneficial antioxidative effects. We aimed to improve the productivity of SOD compared with plant SOD by using a generally regarded as safe [GRAS] microorganism, Bacillus amyloliquefaciens, and assess its antioxidative effect using γ-radiation-and dextransulphate sodium [DSS]-induced oxidative models in mice. Methods: We identified the sodA gene encoding manganese-containing SODs [Mn-SOD] in B. amyloliquefaciens, constructed a Mn-SOD deficient mutant, and screened a high-SOD-producing strain. We compared the antioxidative effect of orally administered enteric-coated SOD protein partially purified from B. amyloliquefaciens with wild-type and high-SOD-producing strain spores. The effect of SOD on DSS-induced colitis was also investigated. Colonic inflammation was assessed using disease activity index, macroscopic and histological damage scores, antioxidant enzyme activities, and inflammatory cytokines. Results: The SOD activity of B. amyloliquefaciens is derived from secreted Mn-SOD encoded by the sodA gene, as shown by comparing sodA knock-out mutant spores with wild-type and high-SODproducing spores. Enteric-coated SOD of B. amyloliquefaciens appears to be effective in reducing oxidative stress in γ-radiation-and DSS-induced mouse models. Co-administration of SOD with wild-type B. amyloliquefaciens or high-SOD-producer strain spores showed a synergistic effect. SOD enzyme and B. amyloliquefaciens spores contribute to the reduction of oxidative stress and inflammatory response in DSS-induced colitis. Conclusions: Mn-SOD of B. amyloliquefaciens could be another source of SOD supplement and may be useful to prevent and treat ulcerative colitis.
Introduction
Oxidative stress, involved in many diseases, is defined as an impaired balance between reactive oxygen species [ROS] production and antioxidant defences. Antioxidant enzymes, such as superoxide dismutase [SOD] , play a key role in diminishing oxidative stress. 1, 2 Thus, the removal of ROS by exogenous SODs has been suggested as an effective preventive strategy against various diseases, and oral supplementation with melon-derived SOD has been shown to have a therapeutic value in both animal and clinical trials. 1, 3 SODs are widely distributed in prokaryotic and eukaryotic cells, and have been classified into four families based on their different types of metal centres [copper/zinc, nickel, manganese, and iron]. 4 Manganesecontaining SODs [Mn-SODs] are widely present in many bacteria, chloroplasts, mitochondria, and cytosol of eukaryotic cells. Mn-SODs in the mitochondria have been suggested to function as tumour suppressors, and cancer cells generally have diminished Mn-SOD activity. 5 Aerobic organisms generate ROS, and environmental stresses induced by a wide range of environmental factors, including heavy metals, can lead to overproduction of ROS and alter intracellular redox status, ultimately leading to cell death. 6 It has been reported that the heavy metal resistance of several Bacillus strains is related to oxidative enzyme activities. 6, 7 The effect of probiotic Bacillus coagulans in alleviating mercury toxicity has also been reported in rats. 8 Ionising radiation exposure causes direct ionisation of cellular atoms and secondary activation, in which energy is transferred to atomic particles, such as electrons, that may lead to changes in cellular function and most commonly activation of cells. Exogenous SOD has been shown to have the ability to repair vegetative B. subtilis cell damage and improve cell survival rate and internal SOD activity in cells irradiated by gamma radiation. 9 A diet containing B. subtilis strain increased the SOD level of serum or tissues significantly in several fish strains. [10] [11] [12] [13] B. subtilis has been found to increase the level of antioxidant enzymes, including SOD, in broiler chickens. 14 These findings led us to develop Bacillus SOD as an alternative antioxidative enzyme for oral supplementation. The microbial fermentation could be extended in capacity relatively easily, and productivity could be maximised through the breeding of the strain and optimisation of fermentation.
B. amyloliquefaciens, recently determined to be a separate species from B. subtilis, produces spores with strong resistance to adverse conditions, making it well-suited for commercial use. 15 In 1999, the Food and Drug Administration [FDA] published a final rule in the Federal Register affirming that carbohydrase and protease enzyme preparations from B. subtilis or B. amyloliquefaciens are generally regarded as safe [GRAS] for use as direct food ingredients. 16 The species traditionally included in the B. subtilis group [B. subtilis, B. licheniformis, B. amyloliquefaciens, and B. pumilus] have also been given a 'Qualified Presumption of Safety' by the European Food Safety Authority. 17 Many studies have reported on the properties of B. amyloliquefaciens, including its antioxidant effects and probiotic potential. [18] [19] [20] [21] [22] [23] [24] [25] B. amyloliquefaciens has also been reported to be useful in the management of inflammatory bowel disease [IBD] . 26 However, there are no studies to date regarding the use of any SOD enzyme from Bacillus strains, including B. amyloliquefaciens. Therefore, we tested B. amyloliquefaciens strain GF423 as a SOD producer.
B. amyloliquefaciens strain GF423, formerly classified as B. polyfermenticus, belongs to the species B. amyloliquefaciens according to molecular taxonomy. It is more closely related to B. amyloliquefaciens FZB42, the type strain of B. amyloliquefaciens subspecies plantarum, than to B. amyloliquefaciens DSM7, the type strain of B. amyloliquefaciens subspecies amyloliquefaciens. Its ability to produce more SOD than wild-type B. amyloliquefaciens renders it an excellent candidate for SOD production for the treatment of inflammatory bowel disease [IBD] .
IBD is a chronic inflammatory disorder of the gastrointestinal tract. Crohn's disease and ulcerative colitis, the two most common clinical forms of IBD, affect millions of patients around the world. 27, 28 Oxidative stress plays a pivotal role in the initiation and progression of IBD. 29 Decreased levels of SOD activity are associated with increased inflammatory processes, indicating that inflammation may be caused by insufficient antioxidant activity in patients with IBD. 30, 31 Since the local colonic delivery of SOD by bacteria is effective in reducing experimental colitis, and lactic acid bacteria [LAB] have been used as vehicles to deliver therapeutic agents in the gut, engineering LAB to produce SOD has been investigated as a supplement to traditional IBD treatments. [32] [33] [34] [35] [36] However, the use of genetically modified bacteria in humans remains difficult to date; therefore, the use of wild-type bacteria selected for their production of SOD, and/or other enzymes that neutralise ROS, may be a more promising means of IBD treatment. 37 Until now, no research regarding oral administration of SOD for IBD treatment has been tried, due to the assumption of its inefficient delivery because of the enzyme's short half-life. However, enteric coatings may make the oral delivery of SOD feasible.
In this work, we identified the Mn-SOD gene of B. amyloliquefaciens, purified the SOD enzyme, and screened a high-SOD-producing strain for the production of SOD on an industrial scale. We also assessed the possibility of enteric-coated SOD as a dietary supplement using γ-radiation-and DSS-induced ulcerative colitis mouse models. 38 with the following primers: 5′ gaagcaaacttaagagtgtg 3′ and 5′ tccttggaagctgtcagtag 3′. The upstream fragment, the EmR gene, and downstream fragment were assembled in order and cloned into the PvuII site of plasmid pUori-ts containing the temperaturesensitive replication origin working in B. subtilis. 39 The resulting plasmid was transformed into B. amyloliquefaciens GF423 by electroporation. 40 The sodA knock-out mutant was selected from the transformants resistant to Em [5 μg/mL] at 42 °C and then plasmidcured at 30 °C. The genomic status around the sodA region was confirmed by PCR and DNA sequencing of the PCR product. The sodA overproducing strain, B. amyloliquefaciens GF424, was selected from a mutant library, which was prepared using ultraviolet [UV] irradiation. 41 The sodA gene of B. amyloliquefaciens GF424 was confirmed to be identical with that of the wild type by DNA sequencing. B. amyloliquefaciens strains were cultivated in tryptic soy broth at 37°C [BD] . PCR was performed using standard methods with Takara Advantage 2 Polymerase. Restriction enzymes and DNA-modifying enzymes were purchased from New England Biolabs [NEB] . All other reagents were purchased from Sigma unless otherwise mentioned.
Materials and Methods

Chemical compounds used
Preparation of test materials
The test materials for oral administration were prepared as follows. For preparation of SOD powder, B. amyloliquefaciens GF424 was grown in tryptic soy broth at 37°C for 24 h. The culture supernatant was collected by centrifugation at 7500 rpm for 10 min at 4°C. The collected supernatant was filtered through 0.25-μM pore-size membrane [Sartorius] and then concentrated 10-fold by ultrafiltration using a polyethersulphone membrane [Sartorius] with a molecular weight cut-off of 10 kDa. Enteric coating was conducted as follows: UF concentrate was mixed with the same volume of 0.1% [w/v] shellac solution dissolved in distilled water and 5% ethanol, and the mixture was lyophilised. For the preparation of the endospore, B. amyloliquefaciens strains were grown in tryptic soy broth at 37°C for about 48 h. The precipitate obtained by centrifugation at 7500 rpm for 10 min at 4°C was washed with phosphare-buffered saline [PBS] solution [Sigma] , and the endospores were purified from the precipitate using the method described by Tavares et al. 42 
Purification and protein analysis
An 800-ml culture supernatant of B. amyloliquefaciens GF423 was collected by centrifugation, and filtered and concentrated as described above. Protamine sulphate was added to the concentrate to reach 0.2% [w/v], followed by centrifugation at 12 000 rpm for 45 
Experimental animals and diet
Six-week-old female Balb/c mice weighing [16] [17] [18] [19] [20] 
Oxidative stress model and SOD treatment
The mice were randomly separated into nine groups [n = 7] . The duration of administration was 28 days in all cases. All spores were administered at a rate of 10 7 /day and all BA SOD at a rate of 10 U/day in 100 µl PBS. The groups included: the control group, which was orally supplemented with 100 µl phosphate-buffered solution [PBS]; the B. amyloliquefaciens SOD [BA SOD] group, which was administered wild-type BASOD; the oxidative stress [OS] control group, supplemented with 100 µl PBS and irradiated with γ-ray 2Gy every 7days; the OS BASOD group, which was administered wild-type BASOD and irradiated with γ-rays at a dose of 2Gy every 7 days; the wild-type B. amyloliquefaciens [BA WT] spore group; the B. amyloliquefaciens sodA knock-out mutant [BA ΔSODA] spore group; the B. amyloliquefaciens high-SOD-producing [BA HPSOD] spore group; the BA WT spore+ BA SOD group, administered full doses of BA WT spore and BA SOD; and the BA HP SOD spore + BA SOD group, administered full doses of BA HP SOD spore and BA SOD. Blood was collected on the first and last days, incubated for 30 min at 25°C, and centrifuged at 1300 rpm for 30 min at 4°C. Supernatants were transferred to a new e-tube and stored at -80°C deep freezer.
DSS-induced IBD and treatment
The mice were divided into eight groups [n = 7]. All spores were administered at a rate of 10 7 /day in 100 µl PBS for 3 weeks, and all DSS was provided as 3% DSS in drinking water for the last 2 weeks. Groups included: the control group, which was administered 100 µl PBS for 3 weeks; the DSS group, administered 100 µl PBS for 3 weeks and provided DSS; the BA WT spore group, administered BA WT spore and provided DSS; the BA ΔSOD spore group, administered BA ΔSOD spore and provided DSS; the BA HP SOD spore group, administered BA HP SOD spore and provided DSS; the BA WT spore + BA SOD group, administered full doses BA WT SOD spore and BA SOD and provided DSS; the BA HP SOD spore + BA SOD group, administered full doses of BA HP SOD spore and BA SOD 10 and provided DSS; and the BA SOD group, administered BA SOD and provided DSS. Blood was collected and tested as described above.
Measurement of the activity index of IBD
The activity index of IBD was evaluated by an independent observer. IBD activity indexes included weight loss, stool consistency, mean score of rectal bleeding, and length of colon. Each score was determined as follows: consistency of stools [score: 0, well-formed pellet; 1, smooth, semi-moulded but not attached to the anus; 2, semi-muolded but attached to the anus; 3, liquid and liquid faeces], rectal bleeding [score: 0, normal; 1, blood traces in rectum; 2, blood in whole rectum; 3, blood traces in both rectum and stool; 4, total rectal bleeding], and weight loss rate calculated as a percentage of baseline body weight [body weight at Day 0].
Measurement of SOD, CAT, and GPx activities
The SOD, CAT, and GPx activities in serum samples were measured according to the manual provided by suppliers of the kits [Cayman Chemical Company, Ann Arbor, MI, USA].
Histology
The colon tissues were fixed in 4% formaldehyde, paraffin-embedded, cleared with xylene, hydrated, and stained with haematoxylin and eosin [H&E] . H&E-stained colonic tissue sections were scored by a blinded observer using a previously published system, for the following measures to grade the extent of inflammatory infiltrate 
Measurement of inflammatory cytokines using ELISA
The levels of inflammatory cytokines IL-1β, TNF-α, and IL-6, were determined using commercial immunoassay kits in accordance with the manufacturer's instructions [R&D systems, Minneapolis, MN, USA].
Statistical analysis
Analyses were performed using Microsoft Excel 2010 for Windows. Quantitative data are shown as mean ± SD. Significance was determined using a two-tailed, unpaired Student's t-test; p-values < 0.05 were considered significant. Thus, to determine whether the SodA of B. amyloliquefaciens GF423 is a major determinant of extracellular SOD activity, the sodA gene was knocked out from its genome as described in the Materials and Methods section, and SOD activity was measured in the culture supernatant of the resulting knock-out mutant. SOD activity was not detected in the sodA knock-out mutant, which suggests that SodA is a major extracellular SOD in B. amyloliquefaciens GF423. This finding corroborates with previous reports that SodA was the only SOD identified in the extracellular fraction in B. subtilis. 45, 46 In addition, we purified the protein into homogeneity from the culture supernatant of B. amyloliquefaciens GF423. The specific activity of the purified SodA was 2360 U/mg. SodA activity was maintained in a pH range of 4.0 to 8.0. The enzyme was stable up to 40°C, and around 60% of activity was retained at 50°C. To improve expression of the sodA gene, B. amyloliquefaciens GF423 was mutagenised by UV irradiation. From the UV mutant library, we selected B. amyloliquefaciens GF424, a strain with 4.5-fold higher SOD activity than that of the wild type. 
Results
Identification of the
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SOD activity of enteric-coated SOD from B. amyloliquefaciens
The enzyme activity of SOD partially purified by ultrafiltration was measured using a commercial kit, and the SOD activity value was 20.24 U/mg [non-coated SOD]. Enteric-coated SOD activity was 3.64 U/mg.
Antioxidant effect of BASOD in mice
To examine the antioxidative effect of BASOD, shellac-coated BASOD was administered to the irradiated mice, and the degree of change of antioxidant enzymes in the blood was measured. The levels of antioxidant enzymes, superoxide dismutase [SOD], catalase [CAT] , and glutathione peroxidase [GPx], were higher in the blood of the BA SOD group than in the control. SOD, CAT, and GPx were also higher in the BA WT spore, BA HPSOD spore, BA WT spore + BA SOD, and BA HPSOD spore + BA SOD groups; levels in the BA ΔSODA spore group were not affected. Contrastingly, antioxidant enzymes of the group irradiated with γ-rays were decreased. In the BA SOD + irradiation group, antioxidant enzymes in the blood recovered to a level similar to that of the control group [ Table 1 ]. These data show that BASOD has an antioxidative effect and can ameliorate oxidative stress.
Effect of BA SOD on DSS-induced IBD in mice
In mouse-modelled DSS-induced ulcerative colitis, BASOD, BA WT spores, and BA HP SOD spores reduced mortality, and BA ΔSODA spores had no effect. Figure 2 shows the outcomes in DSS-treated mice. Survival was the highest in the group treated with both wild-type and high-producing spores [>85%]; survival was greater than 65%, 55%, and 40% of mice treated with only oral SOD, high-producing spore, or wild-type spore, respectively. Mice fed only DSS or DSS + BA ΔSODA spore survived at a rate of 30% [ Figure 2A , B]. Weight loss also differed; the loss rates of the group fed DSS only and DSS + BA ΔSODA spore were greater than those of the control group. Other groups also had greater weight loss than the control group, but loss was less severe [ Figure 2C , D].
BA SOD and SOD-producing BA spore markedly improved clinical signs of DSS-induced colitis, including rectal bleeding [ Figure 3A , B] and diarrhoea [ Figure 3C , D]. The colon length of the group fed only DSS was shorter than that of groups fed DSS + BASOD, DSS + BA spore, and DSS + BASOD + BA spore [ Figure 3E ]. These data show that BASOD and SOD-producing BA spores ameliorate the development of DSS-induced colitis.
Histology of colon tissue
The control group showed histologically normal colonic mucosa. In mice treated with DSS only, the colonic mucosa was severely damaged and a highly inflamed mucosa was observed. A damaged colonic mucosa was also observed in mice treated with DSS and BA ΔSODA spore. In mice treated with DSS and BA SOD, BA WT spore, and/or BA HPSOD spore, some damaged colonic mucosa was observed, but the level was much lower than that of mice treated with DSS alone [ Figure 4A ]. In the mice treated with DSS, inflammation was observed in mucosal and submucosal layers, and the mucous membrane adjacent to the site of ulceration had increased oedema with extensive cell depletion, as compared with the control mice [ Figure 4B ]. After the dietary treatment of BASOD, BA WT spore, and/or BA HPSOD spore, histological analysis revealed a reduction of morphological signs of cell damage. These data indicate that BA SOD and BA spores producing SOD reduce mucosal damage in DSS-induced colitis.
Effect of BA SOD on antioxidant enzymes in serum samples of DSS-induced colitis
The serum SOD level of mice fed only DSS was decreased compared with that of the control group, and the SOD level of mice fed DSS with BA spore or BASOD was higher than that in mice fed only DSS [ Figure 5A ]. CAT and GPx levels of mice fed only DSS were lower than those in the control group, whereas the levels in mice fed DSS with BA spores or BASOD were higher than those in DSS-only mice [ Figure 5B , C]. These data show that BASOD most likely helps to improve colitis by affecting the body's antioxidant enzymes.
Effect of BA SOD on inflammatory cytokines in DSS-induced colitis
Levels of pro-inflammatory cytokines TNFα and IL1β were higher in mice fed only DSS and lower in mice fed DSS with BA SOD or BA spores [ Figure 6A , B]. Levels of IL6, an anti-inflammatory cytokine, decreased in mice fed only DSS and increased in mice fed DSS with BA SOD or BA spores [ Figure 6C ]. These data indicate that BASOD modulates inflammatory cytokines and may thereby improve IBD symptoms.
Discussion
ROS have been implicated in a range of pathologies, such as cancer, cardiovascular diseases [CVDs], degenerative diseases, and infectious diseases. For many scientists studying ROS-related disorders, the manipulation of antioxidant levels offers the possibility to ameliorate particular conditions. 3 Most antioxidants externally provided from dietary sources are quickly saturated and exhausted, whereas SOD keeps eliminating ROS. Therefore, the therapeutic value of oral administration of a combination of melon SOD and a vegetable polymer [gliadin] has been evaluated in many studies. 3 To further clarify the importance of dietary SOD-gliadin administration, additional large-scale clinical trials are proceeding. The use of bacillus SODs could make supplementation with SODs more economical and effective.
Bacillus SODs have been studied from a biochemical and physiological perspective. Mn-SOD [encoded by sodA gene] is essential for resistance to oxidative stress in growing and sporulating cells of B. subtilis. 5 Although many beneficial effects related to increasing SOD levels in animals and humans have been found after administration of bacillus cells, no research has been conducted using bacillus SOD itself, which might be due to its low production level.
Although Mn-SOD is classified as an intracellular protein, it is also consistently found in extracellular protein samples of many bacilli. 5 B. amyloliquefaciens has three sod genes: sodA, sodC, and sodF. The negligible activity of the sodA knock-out mutant demonstrates that that the SOD activity of B. amyloliquefaciens was derived from secreted Mn-SOD encoded by the sodA gene. We therefore isolated a high-SOD-producing strain using UV mutagenesis and developed the downstream process of SOD production. Gliadin has been shown to interact with intestinal epithelial cells and cross the intestinal epithelial barrier. 47, 48 Thus, we chose shellac as an enteric coating material to prolong the half-life of SOD. The specific activity of partially purified SOD using ultrafiltration was 20.24 U/ mg before enteric coating with shellac and 3.64 U/mg after coating; these specific activities are sufficient for commercial use. The reduced mortality and morbidity of mice treated with purified SOD and SOD spores, especially combinations thereof, demonstrate the clinical benefits of this level of SOD activity.
Our results indicated that SOD supplementation not only promoted antioxidant defences [increased SOD, catalase, and GPx activities] but also improved cell resistance to the oxidative stress of γ-irradiation. This result indicates that B. amyloliquefaciens SOD could be an alternative ingredient for dietary supplementation for anti-ageing and well-being in addition to ulcerative colitis. However, the mechanism by which exogenous bacillus SOD promotes antioxidant defences in the body will need to be investigated in further studies.
The scientific community has sought novel therapeutic alternatives to fight IBD and mucositis. As dysbiosis plays a key role in the pathogenesis of both diseases, the modulation of the patient The ability of SOD to control the ROS level within cells renders it a highly effective therapeutic protein for the treatment of IBD. 50 Intestinal inflammation is accompanied by massive ROS production by activated macrophages and neutrophils, which contributes to inflammation-associated tissue destruction. Many studies have documented that exogenous SOD can attenuate inflammation by exerting antioxidative effects on a variety of experimental models, 33 and using GRAS strains as vehicles to deliver bioactive molecules to the gastrointestinal tract has been considered a promising approach for the treatment of many diseases, including IBD. 32 Although bacillus strains have been considered soil organisms for which endospore formation provides a means to ensure long-term survival in the environment, bacillus spores are not transient passengers of the gastrointestinal tract but have adapted to carry out their entire life cycle within this environment. 51 Therefore, the bacillus cytoplasmic protein, which includes SOD, could be released into the gastrointestinal tract through the sporulation life cycle. Moreover, as mentioned above, B. amyloliquefaciens SOD is found extracellularly in liquid culture. Even if the role of SOD in B. polyfermenticus has not been elucidated, the probiotic effect of B. polyfermenticus in intestinal inflammation by suppressing apoptosis and promoting epithelial cell proliferation and migration has been reported. 52 Our results are consistent with these reports. As expected, wild-type B. amyloliquefaciens had a beneficial effect in DSS-induced mouse model, and the effect of the SOD high-producer strain its SOD productivity. Moreover, co-administration of SOD protein with B. amyloliquefaciens spore showed a synergistic therapeutic effect.
Our results are an important step in increasing the accessibility of SOD to IBD patients. Microbial suspension culture is a more convenient mode of mass cultivation of cells, large-scale production, and recovery of enzyme, than plant cultivation. The production of bacillus SOD could be more economical than melon-derived SOD. Moreover, the entire production could take place under highly controlled conditions.
Our findings suggest that the co-administration of enteric-coated SOD with the wild-type strain or the high-SOD-producing strain spores of B. amyloliquefaciens is a promising candidate to alleviate oxidative stress and inflammation response in humans, without the issues regarding the use of genetically modified bacteria as a delivery vehicle of therapeutic protein. However, the acute DSS colitis model is generally considered as a model for acute intestinal inflammation rather than an IBD model. The chronic DSS colitis or IL-10 knockout model would need to be tested.
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